13F Notebook
← Dashboard
Fund detail

Baillie Gifford

large-active, growth, lo

Quarters 52
2019-12-31 $103.48B
Positions 226
Showing 5 of 5 rows (filtered from 231)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 Aslan Pharmaceuticals ADR $0 0 -418,671 -100.00% 0.00%
2 Ctrip.com Intl Sponsored ADR $0 0 -47,161,056 -100.00% 1.57%
3 Evolent Health Inc A $0 0 -1,084,001 -100.00% 0.01%
4 SOLARCITY CORP $0 0 -38,386,000 -100.00% 0.04%
5 Spectrum Brands Holdings Inc $0 0 -335,706 -100.00% 0.02%